Collaborations search results
14 Results for ''
-
Global Development Program
A Solid Foundation The Boston-Cambridge ecosystem, home to numerous prestigious academic institutions, top-tier hospitals, and leaders in the biopharmaceutical industry, is one of the most productive biomedical research ecosystems on earth. The Wyss Institute sits at the nexus of this bustling research-clinical-industry cluster. A powerhouse of cutting-edge research and translation since its founding, the Wyss... -
Nucleic Acid Delivery Consortium
An academic-industry consortium focused on the challenge of delivering nucleic acid-based therapies to specific target organs, tissues, and cells. -
Scientific Instrumentation @ Wyss Collaboratories Program
The Wyss Scientific Instrumentation @ Wyss Collaboratories Program is a unique collaboration between industry manufacturers and our community of scientists and engineers to drive progress and impact, spur entrepreneurship, and incubate innovation. -
Brain Targeted Therapeutic Collaboration
Combine our shuttles with your drugs to create new brain targeted therapeutics for patients. -
Brain Shuttle Research Sponsorship & Licensing
Enabling brain-targeted drug development through non-exclusive licensing and pre-competitive research sponsorship. -
Bridging the Funding Gap for Brain Therapeutics
A unique opportunity to help develop a new generation of brain targeted drugs -
Brigham-Wyss DxA
The Wyss DxA's clinical partners from Brigham and Women’s Hospital identify the most pressing unmet diagnostic needs, provide access to high-quality patient samples for our Biomarker Discovery Laboratory (BDL) and Brigham-Wyss DxA collaborators, and provide invaluable feedback and guidance on the engineering and validation of cost-effective, sensitive, and specific diagnostic tests. -
Biomarker Discovery Laboratory (BDL)
Bridging the diagnostic gap from biomarker discovery to market-ready test kits and instruments through cutting-edge technology development and clinical collaboration. -
Collaborative Fund Venture Alliance
Our alliance with Collab Fund supports sustainable materials to fight climate change. -
Wyss DxA Industrial Participant Program
As the industry-facing component of the Wyss Diagnostics Accelerator, the Industrial Participant Program is a collaboration hub between healthcare testing companies and the scientific and clinical community within the Wyss ecosystem that seeks to compress the timeframe for bringing new, high-impact, diagnostic technologies to market. -
Wyss Brain Targeting Program
Advancing brain delivery approaches that enable more safe and effective brain-targeted therapeutics. -
Wyss Diagnostics Accelerator (DxA)
An initiative to enable the fast creation of diagnostic technologies to solve high-value clinical problems through deep collaborations driven by unmet diagnostic needs. -
Northpond Labs Alliance
Our alliance with Northpond Labs supports early-stage, transformative research with strong translational potential as part of a collaborative Laboratory for Bioengineering Research Innovation. -
i3 Center: Biomaterials to Create T Cell Immunity
Cancer immunologists and biological engineers are developing new biomaterials-based approaches to develop new anti-cancer immunotherapies for treatment-resistant cancers.